Android app Apple app link

AnaptysBio, Inc. (ANAB) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$55.28
Day's range
$59.88

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
03/06/2026 Truist Financial John Lee $50.00 $56.29   -11.17%
03/05/2026 Stifel Nicolaus Alex Thompson $85.00 $57.36   48.18%
03/04/2026 H.C. Wainwright Emily Bodnar $66.00 $58.04   13.72%
01/07/2026 UBS Michael Yee $70.00 $43.91   59.42%
12/17/2025 Barclays Etzer Darout $55.00 $45.03   22.14%
11/10/2025 Wedbush David Nierengarten $50.00 $33.26   50.33%
11/10/2025 Truist Financial Joon Lee $36.00 $34.28   5.03%
10/15/2025 Wedbush David Nierengarten $70.00 $31.85   119.78%
05/06/2025 Guggenheim Yatin Suneja $54.00 $20.12   168.39%
02/03/2025 Wolfe Research Andy Chen $25.00 $16.66   50.06%
12/11/2024 H.C. Wainwright Emily Bodnar $19.00 $15.51   22.5%
11/06/2024 H.C. Wainwright Emily Bodnar $52.00 $19.38   168.32%
11/06/2024 Leerink Partners David Risinger $45.00 $19.38   132.2%
10/21/2024 Guggenheim Yatin Suneja $90.00 $34.98   157.29%
10/15/2024 Piper Sandler Yasmeen Rahimi $80.00 $34.74   130.28%
10/03/2024 New Street David Risinger $35.00 $35.22   -0.62%
08/15/2024 Truist Financial Joon Lee $30.00 $34.65   -13.42%
04/16/2024 Leerink Partners David Risinger $47.00 $21.27   120.97%

AnaptysBio Inc FAQ's

AnaptysBio Inc has been rated by research analysts at UBS, Barclays, Leerink Partners, Truist Financial, Stifel Nicolaus, H.C. Wainwright in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.